Search

Your search keyword '"Míguez-Rey, Enrique"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Míguez-Rey, Enrique" Remove constraint Author: "Míguez-Rey, Enrique"
26 results on '"Míguez-Rey, Enrique"'

Search Results

2. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

3. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

4. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

5. GRALENIA: Antimicrobial Resistance Management based on Natural Language and Artificial Intelligence

7. Role of age and comorbidities in mortality of patients with infective endocarditis

8. Análisis de datos multimodales para la toma de decisiones clínicas utilizando Inteligencia Artificial en el contexto de la COVID-19

9. Explainable learning to analyze the outcome of COVID-19 patients using clinical data

11. Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort.

12. Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

13. Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

14. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

15. Pulmonary nocardiosis treated with tedizolid

16. Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

18. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

19. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

20. Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study

21. Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study

22. Ceftaroline fosamil: clinical experience after 23-month prescription in a tertiary hospital.

23. Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

25. Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine.

Catalog

Books, media, physical & digital resources